Mesenchymal stromal cells alone or expressing interferon-β suppress pancreatic tumors in vivo, an effect countered by anti-inflammatory treatment

References

• Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, . Cancer statistics, 2008. CA Cancer. J Clin. 2008;58:71–96.
   Google Scholar
• Chu GC, Kimmelman AC, Hezel AF, DePinho RA. Stromal biology of pancreatic cancer. J Cell Biochem. 2007;101: 887–907.
   PubMed Web of Science ®Google Scholar
• Studeny M, Marini FC, Dembinski JL, Zompetta C, Cabreira-Hansen M, Bekele BN, . Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. J Natl Cancer Inst. 2004;96:1593–603.
   PubMed Web of Science ®Google Scholar
• Studeny M, Marini FC, Champlin RE, Zompetta C, Fidler IJ, Andreeff M. Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. Cancer Res. 2002;62:3603–8.
   PubMed Web of Science ®Google Scholar
• Studeny M, Marini FC, Zompetta C, Champlin RE, Filder IJ, Andreeff M. Bone marrow derived mesenchymal stem cells serve as precursors for stromal fibroblasts in malignant tumors and show potential for cancer therapy. Blood. 2001;98:697a.
   Google Scholar
• Nakamizo A, Marini F, Amano T, Khan A, Studeny M, Gumin J, . Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res. 2005; 65:3307–3318.
   PubMed Web of Science ®Google Scholar
• Jaster R. Molecular regulation of pancreatic stellate cell function. Mol Cancer. 2004;3:26.
   PubMedGoogle Scholar
• Direkze NC, Hodivala-Dilke K, Jeffery R, Hunt T, Poulsom R, Oukrif D, . Bone marrow contribution to tumor-associated myofibroblasts and fibroblasts. Cancer Res. 2004;64:8492–5.
   PubMed Web of Science ®Google Scholar
• Bachem MG, Schneider E, Gross H, Weidenbach H, Schmid RM, Menke A, . Identification, culture, and characterization of pancreatic stellate cells in rats and humans. Gastroenterology. 1998;115:421–32.
   PubMed Web of Science ®Google Scholar
• Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini FC, Krause DS, . Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8:315–17.
   PubMed Web of Science ®Google Scholar
• Spaeth E, Klopp A, Dembinski J, Andreeff M, Marini F. Inflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cells. Gene Ther. 2008;15:730–738.
   PubMed Web of Science ®Google Scholar
• Li Y, Chopp M, Chen J, Wang L, Gautam SC, Xu YX, . Intrastriatal transplantation of bone marrow nonhematopoietic cells improves functional recovery after stroke in adult mice. J Cereb Blood Flow Metab. 2000;20:1311–19.
   PubMed Web of Science ®Google Scholar
• Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420:860–7.
   PubMed Web of Science ®Google Scholar
• Bissell MJ, Radisky D. Putting tumours in context. Nat Rev Cancer. 2001;1:46–54.
   PubMed Web of Science ®Google Scholar
• Dvorak HF. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med. 1986;315:1650–9.
   PubMed Web of Science ®Google Scholar
• Hall B, Dembinski J, Sasser AK, Studeny M, Andreeff M, Marini F. Mesenchymal stem cells in cancer: tumor-associated fibroblasts and cell-based delivery vehicles. Int J Hematol. 2007;86:8–16.
   PubMed Web of Science ®Google Scholar
• Kidd S, Spaeth E, Klopp A, Andreeff M, Hall B, Marini FC. The (in) auspicious role of mesenchymal stromal cells in cancer: be it friend or foe. Cytotherapy. 2008;10:657–67.
   PubMed Web of Science ®Google Scholar
• Honda T, Rounds BV, Gribble GW, Suh N, Wang Y, Sporn MB. Design and synthesis of 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid, a novel and highly active inhibitor of nitric oxide production in mouse macrophages. Bioorg Med Chem Lett. 1998;8:2711–14.
   PubMed Web of Science ®Google Scholar
• Suh N, Wang Y, Honda T, Gribble GW, Dmitrovsky E, Hickey WF, . A novel synthetic oleanane triterpenoid, 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid, with potent differentiating, antiproliferative, and anti-inflammatory activity. Cancer Res. 1999;59:336–41.
   PubMed Web of Science ®Google Scholar
• Konopleva M, Zhang W, Shi YX, McQueen T, Tsao T, Abdelrahim M, . Synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces growth arrest in HER2-overexpressing breast cancer cells. Mol Cancer Ther. 2006;5:317–28.
   PubMed Web of Science ®Google Scholar
• Liby K, Hock T, Yore MM, Suh N, Place AE, Risingsong R, . The synthetic triterpenoids, CDDO and CDDO- imidazolide, are potent inducers of heme oxygenase-1 and Nrf2/ARE signaling. Cancer Res. 2005;65:4789–98.
   PubMed Web of Science ®Google Scholar
• Dezube BJ, Kurzrock R, Eder JP, Supko JG, Meyer CJ, Camacho LH, . Interim results of a phase I trial with a novel orally administered synthetic triterpenoid RTA 402 (CDDO-Me) in patients with solid tumors and lymphoid malignancies. ASCO Annual Meeting Proceedings Part I. J Clin Oncol. 2007;25:14101.
   Google Scholar
• Ling X, Konopleva M, Zeng Z, Ruvolo V, Stephens LC, Schober W, . The novel triterpenoid C-28 methyl ester of 2-cyano-3, 12-dioxoolen-1, 9-dien-28-oic acid inhibits metastatic murine breast tumor growth through inactivation of STAT3 signaling. Cancer Res. 2007;67:4210–18.
   PubMed Web of Science ®Google Scholar
• Kidd S, Spaeth E, Dembinski JL, Dietrich M, Watson K, Klopp A, . Direct evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescence imaging. Stem Cells. 2009;27:2614–2623.
   PubMed Web of Science ®Google Scholar
• Place AE, Suh N, Williams CR, Risingsong R, Honda T, Honda Y, . The novel synthetic triterpenoid, CDDO-imidazolide, inhibits inflammatory response and tumor growth in vivo. Clin Cancer Res. 2003;9:2798–806.
   PubMed Web of Science ®Google Scholar
• Samudio I, Konopleva M, Hail N Jr, Shi YX, McQueen T, Hsu T, . 2-Cyano-3,12-dioxooleana-1,9-dien-28- imidazolide (CDDO-Im) directly targets mitochondrial glutathione to induce apoptosis in pancreatic cancer. J Biol Chem. 2005;280:36273–82.
   PubMed Web of Science ®Google Scholar
• Binger T, Stich S, Andreas K, Kaps C, Sezer O, Notter M, . Migration potential and gene expression profile of human mesenchymal stem cells induced by CCL25. Exp Cell Res. 2009;315:1468–1479.
   PubMed Web of Science ®Google Scholar
• Wang L, Li Y, Chen X, Chen J, Gautam SC, Xu Y, . MCP-1, MIP-1, IL-8 and ischemic cerebral tissue enhance human bone marrow stromal cell migration in interface culture. Hematology. 2002;7:113–17.
   PubMedGoogle Scholar
• Beckermann BM, Kallifatidis G, Groth A, Frommhold D, Apel A, Mattern J, . VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma. Br J Cancer. 2008;99:622–31.
   PubMed Web of Science ®Google Scholar
• Udani VM, Santarelli JG, Yung YC, Wagers AJ, Cheshier SH, Weissman IL, . Hematopoietic stem cells give rise to perivascular endothelial-like cells during brain tumor angiogenesis. Stem Cells Dev. 2005;14:478–86.
   PubMed Web of Science ®Google Scholar
• De Palma M, Venneri MA, Roca C, Naldini L. Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells. Nat Med. 2003;9:789–95.
   PubMed Web of Science ®Google Scholar
• Lewis CE, Pollard JW. Distinct role of macrophages in different tumor microenvironments. Cancer Res. 2006;66: 605–12.
   PubMed Web of Science ®Google Scholar
• Sato H, Kuwashima N, Sakaida T, Hatano M, Dusak JE, Fellows-Mayle WK, . Epidermal growth factor receptor-transfected bone marrow stromal cells exhibit enhanced migratory response and therapeutic potential against murine brain tumors. Cancer Gene Ther. 2005;12:757–68.
   PubMed Web of Science ®Google Scholar
• Li AL, Li C, Feng YG, Yuan GH, Wang GM, Hao J, . Antileukemic effect of interleukin-7-transduced bone marrow stromal cells in mice following allogeneic T-cell-depleted bone marrow transplantation. Transplant Proc. 2005;37:2297–9.
   PubMedGoogle Scholar
• Zhu W, Xu W, Jiang R, Qian H, Chen M, Hu J, . Mesenchymal stem cells derived from bone marrow favor tumor cell growth in vivo. Exp Mol Pathol. 2006;80:267–74.
   PubMed Web of Science ®Google Scholar
• Kyriakou CA, Yong KL, Benjamin R, Pizzey A, Dogan A, Singh N, . Human mesenchymal stem cells (hMSCs) expressing truncated soluble vascular endothelial growth factor receptor (tsFlk-1) following lentiviral-mediated gene transfer inhibit growth of Burkitt's lymphoma in a murine model. J Gene Med. 2006;8:253–64.
   PubMed Web of Science ®Google Scholar
• Djouad F, Bony C, Apparailly F, Louis-Plence P, Jorgensen C, Noel D. Earlier onset of syngeneic tumors in the presence of mesenchymal stem cells. Transplantation. 2006;82:1060–6.
   PubMed Web of Science ®Google Scholar
• Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, Bell GW, . Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature. 2007;449: 557–63.
   PubMed Web of Science ®Google Scholar
• Maestroni GJ, Hertens E, Galli P. Factor(s) from nonmacrophage bone marrow stromal cells inhibit Lewis lung carcinoma and B16 melanoma growth in mice. Cell Mol Life Sci. 1999;55:663–7.
   Web of Science ®Google Scholar
• Ohlsson LB, Varas L, Kjellman C, Edvardsen K, Lindvall M. Mesenchymal progenitor cell-mediated inhibition of tumor growth in vivo and in vitro in gelatin matrix. Exp Mol Pathol. 2003;75:248–55.
   PubMed Web of Science ®Google Scholar
• Nakamura K, Ito Y, Kawano Y, Kurozumi K, Kobune M, Tsuda H, . Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model. Gene Ther. 2004;11:1155–64.
   PubMed Web of Science ®Google Scholar
• Jiang H, Ren J. Inoculation of murine bone marrow mesenchymal stem cells induces tumor necrosis in mouse with orthotopic hepatocellular carcinoma. Beijing Da Xue Xue Bao. 2008;40:453–8.
   PubMedGoogle Scholar
• Khakoo AY, Pati S, Anderson SA, Reid W, Elshal MF, Rovira II, . Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma. J Exp Med. 2006;203:1235–47.
   PubMed Web of Science ®Google Scholar
• Ganta C, Chiyo D, Ayuzawa R, Rachakatla R, Pyle M, Andrews G, . Rat umbilical cord stem cells completely abolish rat mammary carcinomas with no evidence of metastasis or recurrence 100 days post-tumor cell inoculation. Cancer Res. 2009;69:1815–20.
   PubMed Web of Science ®Google Scholar
• Cousin B, Ravet E, Poglio S, De Toni F, Bertuzzi M, Lulka H, . Adult stromal cells derived from human adipose tissue provoke pancreatic cancer cell death both in vitro and in vivo. PLoS ONE. 2009;4(7):e6278.
   Google Scholar
• Wu GD, Nolta JA, Jin YS, Barr ML, Yu H, Starnes VA, . Migration of mesenchymal stem cells to heart allografts during chronic rejection. Transplantation. 2003;75: 679–85.
   PubMedGoogle Scholar
• Li H, Fu X, Ouyang Y, Cai C, Wang J, Sun T. Adult bone-marrow-derived mesenchymal stem cells contribute to wound healing of skin appendages. Cell Tissue Res. 2006; 326:725–36.
   PubMed Web of Science ®Google Scholar
• Klopp AH, Spaeth EL, Dembinski JL, Woodward WA, Munshi A, Meyn RE, . Tumor irradiation increases the recruitment of circulating mesenchymal stem cells into the tumor microenvironment. Cancer Res. 2007;67:11687–95.
   PubMed Web of Science ®Google Scholar
• Wang L, Li Y, Chen X, Chen J, Gautam SC, Xu Y, . MCP-1, MIP-1, IL-8 and ischemic cerebral tissue enhance human bone marrow stromal cell migration in interface culture. Hematology. 2002;7:113–17.
   PubMedGoogle Scholar
• Schichor C, Birnbaum T, Etminan N, Schnell O, Grau S, Miebach S, . Vascular endothelial growth factor A contributes to glioma-induced migration of human marrow stromal cells (hMSC). Exp Neurol. 2006;199:301–10.
   PubMed Web of Science ®Google Scholar
• Kress CL, Konopleva M, Martinez-Garcia V, Krajewska M, Lefebvre S, Hyer ML, . Triterpenoids display single agent anti-tumor activity in a transgenic mouse model of chronic lymphocytic leukemia and small B cell lymphoma. PLoS ONE. 2007;2(6):e559.
   Google Scholar
• Ling X, Konopleva M, Zeng Z, Ruvolo V, Stephens LC, Schober W, . The novel triterpenoid C-28 methyl ester of 2-cyano-3, 12-dioxoolen-1, 9-dien-28-oic acid inhibits metastatic murine breast tumor growth through inactivation of STAT3 signaling. Cancer Res. 2007;67:4210–18.
   PubMed Web of Science ®Google Scholar
• Konopleva M, Tsao T, Estrov Z, Lee RM, Wang RY, Jackson CE, . The synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces caspase-dependent and -independent apoptosis in acute myelogenous leukemia. Cancer Res. 2004;64:7927–35.
   PubMed Web of Science ®Google Scholar
• Mishra PJ, Mishra PJ, Humeniuk R, Medina DJ, Alexe G, Mesirov JP, . Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells. Cancer Res. 2008;68:4331–9.
   PubMed Web of Science ®Google Scholar
• Spaeth EL, Dembinski JL, Sasser AK, Watson K, Klopp A, Hall B, . Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression. PLoS ONE. 2009; 4(4):e4992.
   PubMedGoogle Scholar